MedTrace Logo

SweMaMi DMI, Microbiome

NCT04346524 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-11-23

No results posted yet for this study

Summary

Dysbiosis is associated with an increased risk of preeclampsia during pregnancy. The microbiome differs between those with and without type 1 diabetes and the cause of type 1 diabetes has been associated with dysbiosis. Increased knowledge of the microbiome and its variation, depending on the state of health during pregnancies complicated with type 1 diabetes, could in the future lead to preventive care and treatments during these pregnancies.

Conditions

Interventions

OTHER

sampling of microbiome

women will sample from vagina, feces, and saliva during pregnancy

Sponsors & Collaborators

Principal Investigators

  • Eva Wiberg-Itzel, PhD · Karolinska Institute Sodersjukhuset Sweden

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04346524 on ClinicalTrials.gov